Ghent University Academic Bibliography

Your filters: cql: author="Henrion, J" or (type any "bookEditor issueEditor" and editor="Henrion, J")

Add to list
- Journal Article
- A1
- open access
Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes

S Van Hees, S Bourgeois, Hans Van Vlierberghe (UGent) , T Sersté, S Francque, P Michielsen, D Sprengers, H Reynaert, J Henrion, S Negrin Dastis, et al.

(2018) ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 47(8). p.1170-1180
Add to list
Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs

A Arain, S Bourgeois, C de Galocsy, J Henrion, P Deltenre, F d'Heygere, C George, B Bastens, L Van Overbeke, R Verrando, et al.

(2016) JOURNAL OF MEDICAL VIROLOGY. 88(1). p.94-99
Add to list
A randomized, open-label, multicenter study evaluating the efficacy of peginterferon alfa-2a versus interferon alfa-2a, in combination with ribavirin, in naïve and relapsed chronic hepatitis C patients

Frederik Nevens, Hans Van Vlierberghe (UGent) , F D'Heygere, J Delwaide, M Adler, J Henrion, A Lenaerts, A Hendlisz, P Michielsen, B Bastens, et al.

(2010) ACTA GASTRO-ENTEROLOGICA BELGICA. 73(2). p.223-228
Add to list
- Journal Article
- A1
- open access
Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust Study

Hans Van Vlierberghe (UGent) , M Adler, B Bastens, Isabelle Colle (UGent) , J Delwaide, J Henrion, Y Horsmans, P Michielsen, P Golstein, JP Mulkays, et al.

(2010) ACTA GASTRO-ENTEROLOGICA BELGICA. 73(1). p.5-11
Add to list
Clinical trial: a randomized trial of pegylated-interferon-alpha-2a plus ribavirin with or without amantadine in treatment-naive or relapsing chronic hepatitis C patients

P. Langlet, F D'Heygere, J Henrion, M Adler, J Delwaide, Hans Van Vlierberghe (UGent) , JP Mulkay, L Lasser, R Brenard, Y Horsmans, et al.

(2009) ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 30(4). p.352-363
Add to list
- Journal Article
- A1
The HepCar registry : report on a one-year registration program of hepatocellular carcinoma (HCC) in Belgium: what is daily practice in HCC?

Hans Van Vlierberghe (UGent) , Isabelle Colle (UGent) , J Henrion, P Michielsen, J Delwaide, H Reynaert, I Borbath, JP Martinet, D Sprenger and R Brenard

(2005) ACTA GASTRO-ENTEROLOGICA BELGICA. 68(4). p.403-411
Add to list
- Journal Article
- A1
The management of patients with mild hepatitis C

C VERSLYPE, P MICHIELSEN, M ADLER, H ORLENT, D SPRENGERS, J DELWAIDE, F D'HEYGERE, P LANGLET, R BRENARD, Isabelle Colle (UGent) , et al.

(2005) ACTA GASTRO-ENTEROLOGICA BELGICA. 68(3). p.314-318
Add to list
- Journal Article
- A1
BASL guidelines for the surveillance, diagnosis and treatment of hepatocellular carcinoma

Hans Van Vlierberghe (UGent) , I BORBATH, J DELWAIDE, J HENRION, P MICHIELSEN and C VERSLYPE

(2004) ACTA GASTRO-ENTEROLOGICA BELGICA. 67(1). p.14-25
Add to list
- Journal Article
- A1
Reduction of relapse rates by 18-month treatment in chronic hepatitis C. A Benelux randomized trial in 300 patients

JT BROUWER, F NEVENS, FC BEKKERING, N BOURGEOIS, Hans Van Vlierberghe (UGent) , CJ WEEGINK, V LEFEBVRE, J VAN HATTUM, J HENRION, J DELWAIDE, et al.

(2004) JOURNAL OF HEPATOLOGY. 40(4). p.689-695
Add to list
- Miscellaneous
Hepatitis C: Screening, treatment and prevention practical guidelines

P MICHIELSEN, R BRENARD, N BOURGEOIS, C DE GALOCSY, J DELWAIDE, J HENRION, Y HORSMANS, F NEVENS, H REYNAERT, G ROBAEYS, et al.

(2003) ACTA GASTRO-ENTEROLOGICA BELGICA. 66(1). p.15-19

Academic Bibliography

Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes

Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs

A randomized, open-label, multicenter study evaluating the efficacy of peginterferon alfa-2a versus interferon alfa-2a, in combination with ribavirin, in naïve and relapsed chronic hepatitis C patients

Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust Study

Clinical trial: a randomized trial of pegylated-interferon-alpha-2a plus ribavirin with or without amantadine in treatment-naive or relapsing chronic hepatitis C patients

The HepCar registry : report on a one-year registration program of hepatocellular carcinoma (HCC) in Belgium: what is daily practice in HCC?

The management of patients with mild hepatitis C

BASL guidelines for the surveillance, diagnosis and treatment of hepatocellular carcinoma

Reduction of relapse rates by 18-month treatment in chronic hepatitis C. A Benelux randomized trial in 300 patients

Hepatitis C: Screening, treatment and prevention practical guidelines

Contents

Support

Contact